Company intelligence / Profile preview

Integumen

York, United Kingdom

Ownership: Private
Employees: ~16
Development stage: Other

Overview

Integumen operates a platform company providing lab-grown human skin testing services to cosmeceutical and skincare companies. The company integrates artificial intelligence to accelerate product formulation screening from up to 18 months to approximately 10 minutes by testing on virtual skin models before physical testing.

Therapeutic areas: OtherWomen's HealthDermatologyInfectious Diseases
Industry: Non-Drug Biotech

Partnerships

Rinocloud (acquired for €3.5 million in 2019 for AI and data management)Modern Water (reagent production)works with top ten cosmeceutical companies globally

Beyond the preview

Go deeper on Integumen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Integumen.

Explore the full profile